Previous Close | 45.05 |
Open | 44.99 |
Bid | 44.70 x 100 |
Ask | 44.95 x 100 |
Day's Range | 44.42 - 45.82 |
52 Week Range | 28.88 - 66.54 |
Volume | |
Avg. Volume | 481,746 |
Market Cap | 1.807B |
Beta (5Y Monthly) | 1.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.81 |
Earnings Date | Nov 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 63.00 |
RxSight (RXST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Last week, you might have seen that RxSight, Inc. ( NASDAQ:RXST ) released its third-quarter result to the market. The...